Carbios: Advancing Towards Commercialisation

 | Oct 15, 2018 05:17AM ET

H118 results were broadly in line with our expectations and Carbios (PA:ALCRB) retains sufficient cash to finance its business until H219. The company continues to make progress with its transformation from a research body to a commercial enterprise. We expect the first commercial revenues from Carbiolice in 2020. Our DCF indicates a valuation for Carbios of €15/share.